Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
W. Yan, N. G. Steele, S. B. Kemp…·F. Bednar
This study shows Notch signaling in tumor-associated macrophages promotes immunosuppression in pancreatic cancer, and blocking it enhances immune therapy effectiveness.
R. E. Menjivar, Z. C. Nwosu, W. Du…·M. di Magliano
This study shows that Arginase 1 suppresses immune responses in pancreatic cancer by inhibiting T cell activation, and targeting it enhances immunotherapy effectiveness.
A. Velez-Delgado, K. L. Donahue, K. L. Brown…·M. Pasca di Magliano
This study shows that extrinsic KRAS signaling reprograms pancreatic fibroblasts to create an inflammatory microenvironment that supports tumor growth.
M. H. Ward, Z. C. Nwosu, P. Poudel…·C. A. Lyssiotis
This study identifies uridine as a novel nutrient for pancreatic cancer cells through uridine phosphorylase 1, showing its role in survival and metabolism under glucose deprivation.
Z. C. Nwosu, H. Giza, M. Nassif…·C. A. Lyssiotis
The paper identifies consistently expressed genes in pancreatic ductal adenocarcinoma (PDAC) to prioritize therapeutic targets and biomarkers.